- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ISPOR 2019: On Location Interviews, Day 1
Interviews with Joey Mattingly, PharmD, MBA, of the University of Maryland School of Pharmacy, and Robert Dubois, MD, PhD, of the National Pharmaceutical Council from day 1 of the ISPOR 2019 annual meeting in New Orleans, Louisiana.
You can also watch day 2 and day 3.
Today, we are on site in New Orleans, Louisiana, at ISPOR’s annual meeting.
We will be recapping some of the top news presented each day at the conference—and soon, we’ll speak with Joey Mattingly, PharmD, MBA, assistant professor of Pharmacy Practice and Science at the University of Maryland School of Pharmacy, and Robert Dubois, MD, PhD, chief science officer and executive vice president of the National Pharmaceutical Council, about different developments in health economics and outcomes research.
Welcome to AJMC® on location! I’m Jaime Rosenberg.
The meeting kicked off today with discussions surrounding innovative ways to deliver healthcare and debates over measures of value, beginning with a session that took a deep dive into how innovative technologies will require innovative ways of thinking about healthcare. There was also a session on global developments in artificial intelligence and machine learning in healthcare, which looked at different challenges and opportunities posed by these developments. Finally, a panel weighed the arguments for and against the use of the quality-adjusted life years for determining the health effects of medical interventions.
Read coverage and watch additional interviews from the meeting at AJMC.com.
That’s all for today. Stay tuned for tomorrow’s AJMC® On Location, where we will sit down with Julia Slejko, PhD, an assistant professor of pharmaceutical health services research at the University of Maryland School of Pharmacy, about incorporating the patient voice into value-based decision making, and Michael Sherman, MD, the chief medical officer of Harvard Pilgrim Health Care, about ICER’s value-based price assessments.
Thank you for watching AJMC® News Network! I’m Jaime Rosenberg
A Look at the Legal and Legislative Landscape Impacting Drug Costs for Patients
October 23rd 2024Kimberly Westrich, MA, of National Pharmaceutical Council, and Adam Colborn, JD, of AMCP, run through the current status of lawsuits and lawmaking at the federal and state levels related to pharmacy benefit managers and cost-shifting programs.
Read More
Dr John M. O'Brien Highlights Critical Role of Rebates in Employer Benefit Choices
August 5th 2024John M. O'Brien, PharmD, MPH, of the National Pharmaceutical Council, discusses his recent study, which sheds light on how important rebates are when choosing benefits for employers and who advises employers on these choices.
Read More
Low-Value Services: Their Impact and Challenges With Addressing Them
May 2nd 2018Jason Buxbaum, MHSA, project manager, V-BID Health; and Robert Dubois, MD, PhD, chief scientific officer, National Pharmaceutical Council, discuss low-value services, their financial impact, what states are doing to address them, and challenges with addressing them.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
